Paul A. Calvo, Ph.D. is a Director at the intellectual property specialty law firm of Sterne, Kessler, Goldstein & Fox P.L.L.C. in Washington, D.C. Dr. Calvo is a member of the firm’s Biotechnology/Chemical Group, and he represents a diverse group of U.S. and international companies innovating in the biotechnology and pharmaceuticals industries. He provides counsel with regard to global patent portfolio strategy, licensing, patent validity, infringement, and design around strategies. Dr. Calvo is experienced in U.S. and international patent procurement and enforcement matters (particularly patent prosecution and oppositions), FDA/ANDA practice, technology transfer, invalidity, noninfringement, freedom-to-operate and patentability opinions, and due diligence investigations.Dr. Calvo has extensive technical expertise in the areas of vaccines, therapeutic antibodies, cellular immunology, cell and molecular biology, proteomics, signal transduction, stem cells, and biotherapeutics. His graduate studies focused on immune responses directed to malarial antigens. During a postdoctoral fellowship at the University of Pennsylvania, Dr. Calvo was awarded a National Research Service Award, sponsored by the National Institutes of Health. That research entailed the examination of cellular biological aspects integral to antigen processing and presentation. Dr. Calvo continued his postdoctoral training in the Laboratory of Viral Diseases in the National Institute of Allergy and Infectious Diseases at the NIH, where he undertook further studies on the cell biological aspects of immune responses and the cellular biology of influenza viruses. Paul A. Calvo, Ph.D. is a Director at the intellectual property specialty law firm of Sterne, Kessler, Goldstein & Fox P.L.L.C. in Washington, D.C. Dr. Calvo is a member of the firm’s Biotechnology/Chemical Group, and he represents a diverse group of U.S. and international companies innovating in the biotechnology and pharmaceuticals industries. He provides counsel with regard to global patent portfolio strategy, licensing, patent validity, infringement, and design around strategies. Dr. Calvo is experienced in U.S. and international patent procurement and enforcement matters (particularly patent prosecution and oppositions), FDA/ANDA practice, technology transfer, invalidity, noninfringement, freedom-to-operate and patentability opinions, and due diligence investigations.Dr. Calvo has extensive technical expertise in the areas of vaccines, therapeutic antibodies, cellular immunology, cell and molecular biology, proteomics, signal transduction, stem cells, and biotherapeutics. His graduate studies focused on immune responses directed to malarial antigens. During a postdoctoral fellowship at the University of Pennsylvania, Dr. Calvo was awarded a National Research Service Award, sponsored by the National Institutes of Health. That research entailed the examination of cellular biological aspects integral to antigen processing and presentation. Dr. Calvo continued his postdoctoral training in the Laboratory of Viral Diseases in the National Institute of Allergy and Infectious Diseases at the NIH, where he undertook further studies on the cell biological aspects of immune responses and the cellular biology of influenza viruses.

Smart Drug Delivery Technology Nano medicine and Drug Delivery Drug targeting Drug Design and Drug Formulation Anti-Cancer Drug Discovery